Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1995 | 06-1995 | 03-1995 | 12-1994 | 09-1994 | |
| Sales | 300 | 16 | 43 | 47 | 105 |
| Gross Profit | 300 | 16 | 43 | 193 | 105 |
| Operating Expenses | 1,052 | 11,190 | 645 | 795 | 788 |
| Operating Income | -752 | -11,174 | -602 | -748 | -683 |
| Interest Expense | 233 | 219 | 6 | 11 | 10 |
| Other Income | -102 | -1 | 0 | 310 | 0 |
| Pre-tax Income | -1,087 | -11,394 | -608 | -449 | -693 |
| Net Income Continuous | -1,086 | -11,394 | -608 | -450 | -692 |
| Net Income | $-1,086 | $-11,394 | $-608 | $-450 | $-692 |
| EPS Basic Total Ops | -2,500.00 | N/A | -5,000.00 | -2,500.00 | -5,000.00 |
| EPS Basic Continuous Ops | -2,500.00 | N/A | -5,000.00 | -2,500.00 | -5,000.00 |
| EPS Diluted Total Ops | -0.50 | N/A | -1.00 | -0.50 | -1.00 |
| EPS Diluted Continuous Ops | -3,620.00 | N/A | -6,080.00 | -4,500.00 | -6,920.00 |
| EBITDA(a) | $-752 | $-11,174 | $-602 | $-748 | $-683 |